Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Short-term Investments (2016 - 2025)

Historic Short-term Investments for CorMedix (CRMD) over the last 10 years, with Q3 2025 value amounting to $8.1 million.

  • CorMedix's Short-term Investments fell 2469.06% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year decrease of 2469.06%. This contributed to the annual value of $11.0 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, CorMedix's Short-term Investments stood at $8.1 million, which was down 2469.06% from $31.4 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Short-term Investments registered a high of $33.3 million during Q3 2023, and its lowest value of $5.0 million during Q1 2021.
  • Its 5-year average for Short-term Investments is $16.7 million, with a median of $15.7 million in 2022.
  • Per our database at Business Quant, CorMedix's Short-term Investments surged by 22876.73% in 2022 and then tumbled by 6771.11% in 2024.
  • CorMedix's Short-term Investments (Quarter) stood at $12.1 million in 2021, then rose by 28.77% to $15.6 million in 2022, then skyrocketed by 112.69% to $33.3 million in 2023, then tumbled by 66.83% to $11.0 million in 2024, then decreased by 26.69% to $8.1 million in 2025.
  • Its last three reported values are $8.1 million in Q3 2025, $31.4 million for Q2 2025, and $11.2 million during Q1 2025.